MedCity Update – November 2014
View this email in your browser

Welcome

From Dr Eliot Forster, Executive Chair of MedCity

Another productive month for MedCity, with successful launches of Angels in MedCity and the OneStart competition, productive work to bring together academia, industry and local government to focus on dementia, and some exciting and high profile science highlighting the excellence of our universities. More details are below, and we are grateful for any help you can provide in highlighting these new opportunities to investors, early-stage companies and aspiring entrepreneurs in your networks.

Closer to home, I am delighted to share the good news that MedCity now has a Chief Operating Officer in the form of Sarah Haywood. Some of you will already know Sarah since she has been critical to the establishment and early success of MedCity in her former role as Head of Life Sciences at London & Partners. Her energy, knowledge and creativity will be a huge asset as we motor ahead.

More good news comes in the form of new Advisory Board member Jo Pisani, Partner, Global Pharmaceuticals and Life Sciences, at PricewaterhouseCoopers, who brings a great depth of industry experience and expertise to the group.

Unlocking investment for life sciences

Exciting early-stage life sciences companies will have a greater shot at commercial success thanks to Angels in MedCity – a tailor-made programme for life sciences investment launched in October. The first free investor workshops take place in November and January, with a pitching event for investment-ready companies in February.
Find more information on upcoming events here
Read more about the initiative here

‘Bespoke’ organs to start clinical trials

How angel investment has helped Videregen take technology to generate replacement organs from a patient’s own stem cells to clinical trials.

Read more

Future of Healthcare Investment Forum

London Stock Exchange and MedCity are hosting their inaugural Future of Healthcare Investment Forum at the London Stock Exchange in January 2015. The one day event will highlight the significant investment opportunities available to generalist and specialist public market investors as well as venture capital representatives within the UK healthcare sectors.
Attendance is by invitation only – email us to find out more.
See more about the event here 

“Animating the cluster is critical”

Figures including Deputy Mayor Kit Malthouse and Minister for Life Sciences spoke at Hume Brophy’s Sixth Annual Investor Relations Healthcare Conference, supported by MedCity. A full report will shortly be available in Hume Brophy’s November newsletter.
Read more about the event here

Digital health focus for London Health Commission

The London Health Commission’s Better Health for London report has unveiled proposals for a Digital Health Institute and Accelerator to support entrepreneurs and map out a clear path to market. MedCity and London’s Academic Health Science Networks are the proposed coordinators of this work, and will respond fully later in the year.

Read more

Mayor calls for investment in International Dementia Research Institute

MedCity and the Mayor of London Boris Johnson host a breakfast bringing together leading pahrmaceutical companies and charities to support the concept of an International Dementia Research Institute.
Read more here

MedCity Lounge at Genesis 2014

MedCity is sponsoring the Source Lounge at this year’s Genesis conference – a relaxed space to find out more about potential partners, clients or investors. This year’s conference takes place on 9 December at the Queen Elizabeth II Conference Centre, Westminster.
Eliot Forster will also be speaking at the Pharma Integrates conference on 18-19 November and Next Steps for Health and Social Care in London on 9 December.
Find out more about Genesis here

Major new cancer investment at Oxford

A new Precision Cancer Medicine Institute at the University of Oxford, in partnership with Oxford University Hospitals Trust, is being founded to drive research into personalised cancer treatments. The new Institute will carry out research into a range of cancer therapies, including advanced cancer imaging, new drugs trials, minimally invasive surgery and proton beam therapy.
Read more

The Great London Tech Census

The Mayor of London has commissioned a detailed analysis of London’s technology sector to support future policy-making. Please help us ensure that life sciences technology business are fully represented.
Fill in the survey here

London’s top 1000 – the innovators

A host of science leaders have made the Evening Standard’s annual list of the top 1000 influential Londoners. Joining a variety of names from Simon Cowell to George Osborne are the Crick’s Sir Paul Nurse, the Wellcome Trust’s Sir William Castell, Cancer Research UK’s Harpal Kumar (all members of MedCity’s Advisory Board) plus Imperial’s Alice Gast, UCL’s Michael Arthur and our own Eliot Forster.
See the full list here

Coming up

Winning business in the US bioscience sector, UKTI
Life Sciences Conference, Queen Mary University of London
London Regenerative Medicine Network November meeting
, LRMN
Institute for Life Sciences university-industry network event, University of Southhampton
Brain health: it takes more than pills and potions, Imperial College London
Can big data attack heart disease?, University College London
The organ lottery, King’s College London
BIA Gala Dinner, BioIndustry Association

Email us to share your event

MedCity was established in April 2014 by the Mayor of London with the capital’s three Academic Health Science Centres – Imperial College Academic Health Centre, King’s Health Partners and UCL Partners.

The next edition of MedCity Update will be sent in the first week of December

Twitter
Twitter

Website
Website

Copyright © 2014 MedCity. All rights reserved